C/EBP homologous protein (CHOP) expressions were discovered to elevate in response to navitoclax treatment in a concentration- and time-dependent manner, thus indicating CHOP association with apoptotic activity of navitoclax in human oral cancer cells (Yang et al., 2019). The gene discussed is DDIT3; the disease is lip and oral cavity carcinoma.